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HR dpldt Vmax Vpm LVEDp Aop
Sinus 95 1719 ± 538 24 ± 0.9 26 ± 1 5.2 ± 08 90 ± 4
RAP 150 1945± 152 24 ± 08 24± 03 44 ± 0.5 94±4
RVSp P 150 1655 ± 399 20±07 2.7 ± 1 5.9 ± 0.9 89±4
RVApP 150 1482 ± 373# 1.7 ±0.1# 2.0 ± 0.6# 8.7 ± 14# 82 ± 4
Cardiac Pacing
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The Impact of Heart Rate on Cerebral Blood Flow in
Patients with Chronic Fatigue, Dizziness and
Episodic Weakness After Implantation of Permanent
Pacing Devices
Andreas Hagendorff, Christian Dettmers, Luciano Pizzulli, Heyder amran,
Alexander Hartmann, Berndt LOderitz. Departments of Cardiology and Neurology,
University of Bonn, Bonn, Germany
#P < 0.05 compared with sinus, RAP and Sp Pvalues
Conclusion: RV Sp P normalizes and significantly improves paced LV func-
tion over RV Ap P. In spite of loss of AV synchrony, LV function is comparable
to sinus and RAP in pts without inherent myocardial dysfunction. This im-
provement in paced LV hemodynamics should be considered for any age pt
requiring chronic single or dual chamber V P.
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Septal Pacing Improves Single Chamber-paced Left
Ventricular Function: A Comparative Evaluation with
Atrial and Apical Pacing
Peter P. Karpawich, Seema Mita!. Children's Hospital of Michigan, Wayne State
University School ofMedicine, Detroit. MI
Right (R) ventricular (V) apical (Ap) pacing (P) alters left (L) V contraction com-
pared to normal and may predispose to decreased LVfunction. RV septal (Spl
P maintains more normalized V depolarization and contraction patterns to
improve paced LV hemodynamics and may be better suited as an electrode
implant site. To evaluate efforts of pacing site on paced LV function in young
hearts without coronary artery disease or intrinsic LV dysfunction. 17 pa-
tients (pts) (age 1-17 y. median 10) with normal cardiac anatomy underwent
comparative LV hemodynamic evaluations during electrophysiologic studies.
In each pt, LV function was assessed by measurement of LV end-diastolic
pressure (p) (EDp), mean aortic (Ao) p (mmHg), LV dp/dt (mmHg/sec), Vmax
(circ/sec), and Vpm (eire/sec) during sinus rhythm and after 20 min of Peach
from R atrium (A), RV Ap and RV Sp at 150 ppm to mimic exercise. Opti-
mal Sp P site was confirmed by recording a His bundle potential from the
transvenous P catheter placed across the septal-tricuspid valve annulus.
Results (mean ± sem): Sp P showed no significant differences from sinus
or atrial Pvalues. RV Ap P showed significantly worse LV function compared
withSpP.:
Experimental investigations of our laboratory has shown that cerebral blood
flow (CBF) is more reduced by arrhythmia-induced borderline hypotension
than by hypovolemic hypotension. This effect is mainly caused by an impair-
ment of the capacity of CBF regulation. In patients with syncopies neurolog-
ical symptoms like fatigue, dizziness and weakness are often observed de-
spite pacemaker implantation, especially in elderlies. We hypothetized that
an impairment of the CBF regulation combined with episodes of hypotension
or low cardiac output might be the reason for these complaints. Therefore
the aim of the present study was to investigate the effect of pacing with an
increased heart rate on CBF in patients with unspecific neurological symp-
toms.
Methods: CBF was measured with the 133-Xenon method in 12 patients
(coronary artery diesease: n = 8; previous myocardits: n = 4) with implanted
pacemakers (DOD-mode: n = 7; WI-mode: n = 5) during control conditions
at a heart rate of 50 to 70 ppm (A). Regulation of CBF was tested by the
5% carbon dioxide inhalation test which normally induces a marked CBF
increase due to the arterial hypercapnia (B). In addition, CBF was measured
during cardiac pacing at a heart rate of 120 to 130 ppm (C).
Results: Measurements were performed during normotension and arterial
normoxia. Mean values of CBF in group A, Band Cwere 70 ± 7, 94 ± 10 and
68 ± 8 ml/1 00 g/min, respectively. In group B a uniform, significant increase
of CBF was observed in all patients (p :::: 0.01). In group C different CBF-
responses were found: a slight CBF increase of 5% (n = 4), a distinct CBF
increase of 15 to 20% (n = 2). no changes of CBF (n = 5), a CBF reduction
of 18% (n = 1).
'G IO Pre Post Pre Post%E ~E~ 40II..:I: 20II..II.> 0 0 20a:
fects of LVAD on RV performance have been difficult to evaluate. To deter-
mine the feasibility of a new method to assess RV performance with LVAD,
6 pts aged 44 ± 14 yrs, were studied before and immediately after Nova-
cor LVAD implantation. Simultaneous measures of RV cross-sectional area
by transesophageal echo automated border detection and high fidelity pres-
sure were used to construct pressure-area loops on-line. Data were acquired
during steady state apnea and with IVC occlusions (example shown). The fol-
lowing RV indices were obtained: maximum & minimum areas, 20 ejection
fraction (2DEF). systolic pressure, stroke force (SF) f pressure d area, end-
systolic elastance (Ees). and preload recruitable SF (PRSF).
An immediate decrease in RV systolic pressure (35 ± 7 to 28 ± 6 mmHg,
p < 0.05) and an immediate increase in RV ejection (RV 2DEF: 21 ± 8 to
33 ± 12%, P < 0.05) occurred with LVAD. No significant changes occurred
in RV SF; 123 ± 64 to 124 ± 65 mmHg-cm2, Ees; 5.7 ± 3.8 to 3.5 ± 1.4
mmHg/cm2, or PRSF; 18 ± 14 to 19 ± 15 mmHg. These data support the
unloading effect of LVAD on improving RV ejection, rather than improved RV
contractility. Automated pressure-area relations may have potential to assess
the effects of LVAD on RV performance.
Etiology of CA N % Survivors %
Myocardial Infarction 70/173 40% 18f70 26%
Post Bypass Graft Surgery 8/173 5% 3/8 38%
Angioplasty Failure 67/173 39% 25/67 37%
Trauma 3/173 1% 0/3 0%
Pulmonary Emboli 10/173 6% 1110 10%
Other 15/173 9% 6115 40%
34% (89/258) of all pts survived. When flow was established on CPS in <20
minutes, 80/208 (38%) survived. When flow was established in >20 minutes
only 9rSO pts (18%) survived; 6 of these 9 pts (67%) had flow established
in 20-25 minutes. Pts who had CPS placed in the cath lab resulted in 41 %
survivorship (76/185).
Of the 258 pts treated, 118 were sent to emergency surgery. Of these,
50/118 (42%) survived to hospital discharge.
Conclusions: CPS is a justifiable technique for selected pts in CA or refrac-
tory CS particularly in the cardiac cath lab. Complete surgical revasculariza-
tion post CPS may offer even better survivorship.
9:45
1739-61 Emergency Cardiopulmonary Support in Cardiac
Arrest and Cardiogenic Shock: Enhanced Survival
from the Registry
Paul A. Overlie, Fayaz A. Shawl, Robert A. Vogel, Michael R. Mooney, Sidney
C. Smith, Jr., Simon Sterner, National Registry of Emergency Cardiopulmonary
Bypass Registry Investigators. MethodistlStMaryHospitals, l.J.Jbbock, Texas
Despite thorough training in advanced cardiac life support, treatment of car-
diac arrest (CA) and cardiogenic shock (CS) has not increased survival rates
from in-hospital catastrophes. This report of the National Registry for Emer-
gency Cardiopulmonary Bypass (CPS) describes outcomes in 258 consecu-
tive patients (pts) treated at the participating institutions.
Of these pts, 173 had initial CA and 77 presented with CS uresponsive
to pressors. Eight were in other categories including a frozen aortic valve
prosthesis, embolic stroke, dissection, papillary muscle rupture, tamponade,
ventricular-tachycardia, subtotal left main with electromechanical dissocia-
tion. CPS placement occurred: cath lab (N = 185). Emergency room (N =
10), Intensive Care Unit (N = 25), Ward (N = 9), and other IN = 29).
